Ionolyte (Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Sodium Acetate Trihydrate)

Ionolyte is used for fluid and electrolyte replacement in clinical situations that involve loss or imbalance of key electrolytes.

• Electrolyte replacement: restores sodium, potassium, magnesium and acetate levels in patients with deficits.
• Fluid resuscitation: expands intravascular volume in hypovolemic patients.
• Surgical peri‑operative care: maintains electrolyte balance during major operations.
• Critical care: supports patients with severe electrolyte disturbances in intensive care units.

• Ionolyte delivers magnesium, potassium, sodium and acetate ions directly into the bloodstream via intravenous infusion. The sodium and chloride components increase extracellular fluid volume, while potassium and magnesium replenish intracellular stores. Acetate is metabolized to bicarbonate, helping to correct metabolic acidosis. Together, these ions restore osmotic balance, support cellular function, and maintain acid‑base homeostasis. By providing these essential electrolytes, the solution assists in stabilizing cardiac electrophysiology and neuromuscular activity.

Ionolyte may be associated with adverse reactions typical of intravenous electrolyte solutions.

Common Side Effects

• Injection site irritation: pain, redness or swelling at the infusion site.
• Electrolyte overshoot: transient hypernatremia, hyperkalemia, or hypermagnesemia.
• Metabolic alkalosis: due to acetate conversion to bicarbonate.
• Hypotension: mild drop in blood pressure during rapid infusion.
• Fluid overload: signs of pulmonary edema in susceptible patients.

Serious or Rare Side Effects

• Severe hyperkalemia: can cause cardiac arrhythmias.
• Severe hypermagnesemia: may lead to respiratory depression.
• Anaphylactic reaction: rare hypersensitivity to solution components.

When using Ionolyte, clinicians should observe specific precautions to minimize risks.

• Assess baseline electrolytes: obtain serum sodium, potassium, magnesium and acid‑base status before infusion.
• Adjust infusion rate: avoid rapid administration to prevent fluid overload and electrolyte shifts.
• Monitor cardiac rhythm: watch for arrhythmias especially in patients with renal impairment.
• Renal function: reduce dose or increase monitoring in patients with decreased kidney clearance.
• Pregnancy and lactation: use only if clearly indicated and benefits outweigh potential risks.
• Store at ambient temperature: keep below 25°C, protect from moisture and light, and use within the labeled expiry.

Ionolyte can interact with other medications that affect electrolyte balance or cardiac conduction.

Major Interactions (Avoid)

• Potassium‑sparing diuretics: may cause dangerous hyperkalemia when combined.
• Magnesium‑containing laxatives or antacids: increase risk of hypermagnesemia.
• Calcium channel blockers: additive effects on cardiac conduction with electrolyte shifts.

Moderate Interactions (Monitor Closely)

• ACE inhibitors or ARBs: monitor potassium levels closely.
• Loop diuretics: may require adjustment of electrolyte supplementation.
• Insulin therapy: insulin drives potassium into cells, increasing risk of hypokalemia after infusion.